Exposure to herpes simplex virus, type 1 and reduced cognitive function

Journal of Psychiatric Research

Volumn 47, Issue 11, 2013, Pages 1680-1685

  Thomas, Pramod ^a   Bhatia, Triptish ^b   Gauba, Deepak ^c   Wood, Joel ^d   Long, Colleen ^d   Prasad, Konasale ^d   Dickerson, Faith B ^e   Gur, Raquel E ^f   Gur, Ruben C ^f   Yolken, Robert H ^g   Nimgaonkar, Vishwajit L ^d,h   Deshpande, Smita N ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c BSES Bhawan   (India)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e SHEPPARD PRATT HEALTH SYSTEM   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Herpes simplex; HSV 1; Memory; Schizophrenia; Virus

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; EXPOSURE; FEMALE; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; UNIVARIATE ANALYSIS;

COGNITION; HERPES SIMPLEX; HSV-1; MEMORY; SCHIZOPHRENIA; VIRUS;

ADULT; ATTENTION; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HERPES SIMPLEX; HUMANS; IMMUNOGLOBULIN G; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; ORIENTATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SIMPLEXVIRUS; VIRAL PROTEINS; YOUNG ADULT;

EID: 84884418445     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.07.010     Document Type: Article

References (39)

1. Aiello A.E., Haan M., Blythe L., Moore K., Gonzalez J.M., Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatrics Society 2006, 54:1046-1054.
2. Baringer J.R., Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Annals of Neurology 1994, 36:823-829.
3. Becker Y. HSV-1 brain infection by the olfactory nerve route and virus latency and reactivation may cause learning and behavioral deficiencies and violence in children and adults: a point of view. Virus Genes 1995, 10:217-226.
4. Bhatia T., Agarwal A., Shah G., Wood J., Richard J., Gur R.E., et al. Adjunctive cognitive remediation for schizophrenia using yoga: an open, non-randomized trial. Acta Neuropsychiatrica 2012, 24:91-100.
5. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. American Journal of Psychiatry 2010, 167:261-280.
6. Calkins M.E., Tepper P., Gur R.C., Ragland J.D., Klei L., Wiener H.W., et al. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. American Journal of Psychiatry 2010, 167(4):459-472.
7. Calkins M.E., Ray A., Gur R.C., Freedman R., Green M.F., Greenwood T.A., et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry 2013, 73(10):976-984.
8. Cleator G.M., Klapper P.E. Herpes simplex. Principles and practice of clinical virology 2004, John Wiley & Sons, Ltd, New York. A.J. Zuckerman, J.E. Banatvala, R.J. Pattison (Eds.).
9. Deshpande S.N., Mathur M.N., Das S.K., Bhatia T., Sharma S., Nimgaonkar V.L. AHindi version of the diagnostic interview for genetic studies. Schizophrenia Bulletin 1998, 24:489-493.
10. Dickerson F., Stallings C., Origoni A., Boronow J., Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophrenia Research 2007, 93(1-3):261-265.
11. Dickerson F., Stallings C., Sullens A., Origoni A., Leister F., Krivogorsky B., et al. Association between cognitive functioning, exposure to herpes simplex virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder. Brain, Behavior, and Immunity 2008, 22:1103-1107.
12. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Krivogorsky B., et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biological Psychiatry 2004, 55:588-593.
13. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Ruslanova I., Yolken R.H. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Archives of General Psychiatry 2003, 60:466-472.
14. Gur R.C., Ragland J.D., Moberg P.J., Bilker W.B., Kohler C., Siegel S.J., et al. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology 2001, 25:777-788.
15. Gur R.C., Ragland J.D., Moberg P.J., Turner T.H., Bilker W.B., Kohler C., et al. Computerized neurocognitive scanning: I. Methodology and validation in healthy people. Neuropsychopharmacology 2001, 25:766-776.
16. Gur R.E., Calkins M.E., Gur R.C., Horan W.P., Nuechterlein K.H., Seidman L.J., et al. The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin 2007, 33:49-68.
17. Gur R.E., Nimgaonkar V.L., Almasy L., Calkins M.E., Ragland J.D., Pogue-Geile M.F., et al. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. American Journal of Psychiatry 2007, 164:813-819.
18. Gur R.C., Richard J., Hughett P., Calkins M.E., Macy L., Bilker W.B., et al. Acognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation. Journal of Neuroscience Methods 2010, 187(2):254-262.
19. Gur R.C., Richard J., Calkins M.E., Chiavacci R., Hansen J.A., Bilker W.B., et al. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology 2012, 26(2):251-265.
20. Math S.B., Chandrashekar C.R., Bhugra D. Psychiatric epidemiology in India. Indian Journal of Medical Research 2007, 126:183-192.
21. Nelson C.T., Demmler G.J. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clinics in Perinatology 1997, 24:151-160.
22. Pandurangi A.K., Pelonero A.L., Nadel L., Calabrese V.P. Brain structure changes in schizophrenics with high serum titers of antibodies to herpes virus. Schizophrenia Research 1994, 11:245-250.
23. Prasad K.M., Eack S.M., Goradia D., Pancholi K.M., Keshavan M.S., Yolken R.H., et al. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. American Journal of Psychiatry 2011, 168:822-830.
24. Prasad K.M., Eack S.M., Keshavan M.S., Yolken R.H., Iyengar S., Nimgaonkar V.L. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophrenia Bulletin 2012, 39(4):857-866.
25. Prasad K.M., Shirts B.H., Yolken R.H., Keshavan M.S., Nimgaonkar V.L. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Molecular Psychiatry 2007, 12:105-113.
26. Prasad K.M., Watson A.M., Dickerson F.B., Yolken R.H., Nimgaonkar V.L. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophrenia Bulletin 2012, 38:1137-1148.
27. Riffelmann M., Thiel K., Schmetz J., Wirsing von Koenig C.H. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Journal of Clinical Microbiology 2010, 48:4459-4463.
28. Schretlen D.J., Vannorsdall T.D., Winicki J.M., Mushtaq Y., Hikida T., Sawa A., et al. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophrenia Research 2010, 118:224-231.
29. Shirts B.H., Prasad K.M., Pogue-Geile M.F., Dickerson F., Yolken R.H., Nimgaonkar V.L. Antibodies to cytomegalovirus and herpes simplex virus 1 associated with cognitive function in schizophrenia. Schizophrenia Research 2008, 106:268-274.
30. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. Journal of Infectious Diseases 2002, 186(Suppl 1):S3-S28.
31. Srikanth S., Ravi V., Poornima K.S., Shetty K.T., Gangadhar B.N., Janakiramaiah N. Viral antibodies in recent onset, nonorganic psychoses: correspondence with symptomatic severity. Biological Psychiatry 1994, 36:517-521.
32. Steiner I., Kennedy P.G., Pachner A.R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. The Lancet Neurology 2007, 6:1015-1028.
33. Strandberg T.E., Pitkala K.H., Linnavuori K.H., Tilvis R.S. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 2003, 34:2126-2131.
34. Thomas P., Mathur P., Gottesman I.I., Nagpal R., Nimgaonkar V.L., Deshpande S.N. Correlates of hallucinations in schizophrenia: a cross-cultural evaluation. Schizophrenia Research 2007, 92:41-49.
35. Watson A.M., Prasad K.M., Klei L., Wood J.A., Yolken R.H., Gur R.C., et al. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychological Medicine 2012, 1-9.
36. Weiner M.W., Sadowsky C., Saxton J., Hofbauer R.K., Graham S.M., Yu S.Y., et al. Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease. Alzheimer's & Dementia 2011, 7:425-435.
37. Whitley R. Herpes simplex virus infections. Cecil medicine 2011, Saunders Elsevier, Philadelphia, (pp. chap 382.). L. Goldman, A.I. Schafer (Eds.).
38. Yolken R.H., Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995, 8:131-145.
39. Yolken R.H., Torrey E.F., Lieberman J.A., Yang S., Dickerson F.B. Serological evidence of exposure to herpes simplex virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res 2011, 128:61-65.